| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1839538-24-7 | 3,5-Diaminobenzoic acid 4-(trans-4-heptylcyclohexyl)phenyl ester | Csub26/subHsub36/subNsub2/subOsub2/sub |
| 1839619-50-9 | Enzalutamide Impurity B | Csub17/subHsub8/subFsub6/subNsub4/subS |
| 1840966-49-5 | Isoleojaponin | Csub20/subHsub26/subOsub3/sub |
| 1841081-72-8 | 1-(2-Ethoxyethyl)-2-(4-piperidinyl)-1H-benzimidazole hydrochloride (1:1) | Csub16/subHsub23/subNsub3/subO.HCl |
| 1841139-28-3 | 5-(6-(2-(3-Ethyl-1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)ethylidene)-2-(2-(3-ethyl-1,1-dimethyl-1H-benzo[e]indol-3-ium-2-yl)vinyl)cyclohex-1-en-1-yl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate | Csub48/subHsub50/subNsub4/subOsub3/sub |
| 1841445-60-0 | 4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-hydroxy-1-[2-(2-hydroxyethoxy)ethyl]-piperazinium | Csub21/subHsub26/subNsub3/subOsub3/subS |
| 1843368-38-6 | (2S)-2-[[(4-Hydroxyphenyl)methyl]amino]propanamide | Csub10/subHsub14/subNsub2/subOsub2/sub |
| 1844830-65-4 | c(phg-isoDGR-(NMe)k) | Csub27/subHsub41/subNsub9/subOsub7/sub |
| 1844894-70-7 | Vildagliptin Dione Impurity | Csub17/subHsub24/subNsub2/subOsub3/sub |
| 1845687-62-8 | 3-Pyridazineacetic acid lithium salt | Csub6/subHsub5/subNsub2/subOsub2/sub.Li |
| 1846558-62-0 | [5-[Bis(1,1-dimethylethyl)phosphino-kappap]-1',3',5'-triphenyl-1,4'-BI-1H-pyrazole][(1,2,3-eta)-1-phenyl-2-propen-1-YL]-palladium(1+), 1,1,1-trifluoromethanesulfonate (1:1) | Csub42/subHsub42/subFsub3/subNsub4/subOsub3/subPPdSsup-sub4/sub/sup |
| 1848244-75-6 | [2',4'-Bis(1,1-dimethylethyl)-6'-methoxy[1,1'-biphenyl]-2-yl]dicyclohexylphosphine | Csub33/subHsub49/subOP |
| 1848959-10-3 | TAS4464 | Csub21/subHsub23/subFNsub6/subOsub6/subS |
| 1849292-73-4 | 1-(3-Fluoro-3-(hydroxymethyl)azetidin-1-yl)ethan-1-one | Csub6/subHsub10/subFNOsub2/sub |
| 1849590-01-7 | 6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione | Csub17/subHsub20/subNsub6/subOsub2/sub |
| 1849594-85-9 | 5-Bromo-1,6-dihydro-3-methyl-6-oxo-2-pyridinecarboxylic acid ethyl ester | Csub9/subHsub10/subBrNOsub3/sub |
| 1849616-42-7 | Lipid ALC-0159 | |
| 1850305-79-1 | N-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl]carbamic acid 1,1-dimethylethyl ester | Csub13/subHsub26/subBNOsub4/sub |
| 1850305-80-4 | N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propyl]carbamic acid 1,1-dimethylethyl ester | Csub14/subHsub28/subBNOsub4/sub |
| 1852465-76-9 | 4-[1,1'-Biphenyl]-3-yl-6-chloro-2-phenylpyrimidine | Csub22/subHsub15/subClNsub2/sub |
| 1853122-02-7 | N-(4-(9-Phenyl-9H-fluoren-9-yl)phenyl)-[1,1'-biphenyl]-4-amine | Csub37/subHsub27/subN |
| 1853279-29-4 | [(7alpha,17beta)-17-Hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]boronic acid | Csub32/subHsub48/subBFsub5/subOsub4/subS |
| 1853997-27-9 | 2-(4-Bromo-1-naphthalenyl)-1,10-phenanthroline | Csub22/subHsub13/subBrNsub2/sub |
| 1854067-25-6 | (R)-1-[(S)-2-(2'-Diphenyphosphinophenyl)ferrocenyl]ethyldiphenylphosphine | Csub42/subHsub31/subFePsub2/sub |
| 1854067-37-0 | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(diphenylphosphino)phenyl]ferrocene | Csub38/subHsub44/subFePsub2/sub |
| 1854067-50-7 | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(dicylohexylphosphino)phenyl]ferrocene | Csub38/subHsub56/subFePsub2/sub |
| 1854067-58-5 | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(dicylohexylphosphino)phenyl]ferrocene | Csub38/subHsub56/subFePsub2/sub |
| 1854067-62-1 | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene | Csub34/subHsub52/subFePsub2/sub |
| 1854067-71-2 | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene | Csub34/subHsub52/subFePsub2/sub |
| 1855006-12-0 | Regorafenib EP Impurity C | Csub20/subHsub18/subFNsub5/subOsub3/sub |
| 1855920-54-5 | 3-chloro Rivaroxaban | Csub19/subHsub18/subClNsub3/subOsub5/subS |
| 1858267-99-8 | 2-[[(3aR,4S,6R,6aS)-6-[7-Amino-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol | Csub17/subHsub26/subNsub6/subOsub4/subS |
| 1858289-64-1 | 4-[1,1'-Biphenyl]-3-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzothiophene | Csub30/subHsub27/subBOsub2/subS |
| 1859053-21-6 | (1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid compd. with 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one (1:1) | Csub19/subHsub18/subFNsub3/subO.Csub10/subHsub16/subOsub4/subS |
| 1859162-80-3 | Sofosbuvir Impurity 93 | Csub16/subHsub20/subFNsub2/subOsub8/subP |
| 1860012-45-8 | tert-Butyl N-[(2S,3S)-2-methylpiperidin-3-yl]carbamate | Csub11/subHsub22/subNsub2/subOsub2/sub |
| 1860012-52-7 | (3R,5S)-3-Amino-5-methyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | Csub11/subHsub22/subNsub2/subOsub2/sub |
| 1860793-92-5 | Hexahydro-6-(phenylmethyl)-pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione | Csub14/subHsub17/subNsub3/subOsub2/sub |
| 1860875-51-9 | 4-Chloro-N-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]methyl]-α,α-difluorobenzeneacetamide | Csub22/subHsub18/subClFsub2/subNsub3/subOsub4/sub |
| 1862216-82-7 | Ethyl 9-phenyl-9H-carbazole-3-carboxylate | Csub21/subHsub17/subNOsub2/sub |
| 1863098-74-1 | Cyclopropyl(4,6-dichloropyridin-3-yl)methanonethanone | Csub9/subHsub7/subClsub2/subNO |
| 1863930-34-0 | Azilsartan Impurity F | Csub23/subHsub23/subNsub3/subOsub3/sub |
| 1864063-95-5 | 1H-Pyrrolo[3,2-c]pyridine-4-carboxylic acid hydrochloride (1:1) | Csub8/subHsub6/subNsub2/subOsub2/sub.HCl |
| 1864897-67-5 | 2-Hydroxy-N-(pyridin-4-yl)butanamide | Csub9/subHsub12/subNsub2/subOsub2/sub |
| 1866059-82-6 | 1,1,2,2-Tetrafluoro-3-methylsulfonylpropane | Csub4/subHsub6/subFsub4/subOsub2/subS |
| 1867162-18-2 | 6-Chloro-2-oxo-4-methylchromen-7-yl 4-O-beta-D-xylopyranosyl-beta-D-xylopyranoside | Csub20/subHsub23/subClOsub11/sub |
| 1868064-50-9 | Abiraterone Acetate 5,6-Epoxide | Csub26/subHsub33/subNOsub3/sub |
| 1868232-32-9 | (R)-N-Cyclohexyl-3-[(3,4-dichlorophenethyl)amino]-N-[2-[[2-hydroxy-2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl]amino]ethyl]propanamide | Csub29/subHsub38/subClsub2/subNsub4/subOsub4/sub |
| 1869075-89-7 | Bendamustine USP Related Compound F | Csub22/subHsub33/subClsub2/subNsub3/subOsub7/sub |
| 1869082-57-4 | 9,10-Didehydroeffususol A | Csub18/subHsub18/subOsub3/sub |